Amendment No. 8

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G/A

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)1

 

 

 

 

Harvard Bioscience, Inc.

(Name of issuer)

 

 

Common Stock, par value $.01 per share

(Title of class of securities)

 

 

416906 10 5

(CUSIP number)

 

 

December 31, 2008

(Date of event which requires filing of this statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

(Continued on the following pages)

  

 

1

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 5


SCHEDULE 13G/A

CUSIP No. 416906 10 5

 

  1  

NAME OF REPORTING PERSONS

 

            Chancey Graziano

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            United States of America

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            4,864,882

 

  6    SHARED VOTING POWER

 

            None

 

  7    SOLE DISPOSITIVE POWER

 

            4,864,882

 

  8    SHARED DISPOSITIVE POWER

 

            None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            4,864,882

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            15.4%

   
12  

TYPE OF REPORTING PERSON*

 

            IN

   

 

Page 2 of 5


STATEMENT ON SCHEDULE 13G/A

Item 1.  

(a)

   Name of Issuer.      
     Harvard Bioscience, Inc.      
 

(b)

   Address of Issuer’s Principal Executive Offices      
    

84 October Hill Road

Holliston, Massachusetts 01746

     
Item 2.  

(a)

   Name of Person Filing      
     Chancey Graziano      
 

(b)

   Address of Principal Business Office or, if none, Residence      
    

84 October Hill Road

Holliston, Massachusetts 01746

     
 

(c)

   Citizenship      
     United States of America      
 

(d)

   Title of Class of Securities      
     Common Stock, par value $.01 per share      
 

(e)

   CUSIP Number      
     416906 10 5      
Item 3.   If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:   
        Not applicable      
  (a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c)    ¨    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d)    ¨    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
  (e)    ¨    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g)    ¨    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  (h)    ¨    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j)    ¨    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Page 3 of 5


STATEMENT ON SCHEDULE 13G/A

Item 4.    Ownership      
   (a)    Amount beneficially owned:      
      4,864,882      
   (b)    Percent of class:      
      15.4%      
   (c)    Number of shares as to which the person has:      
      (i)    Sole power to vote or to direct the vote:      
         4,864,882      
      (ii)    Shared power to vote to direct the vote:      
         None      
      (iii)    Sole power to dispose or to direct the disposition of:      
         4,864,882      
      (iv)    Shared power to dispose or to direct the disposition of:      
         None      
Item 5.    Ownership of Five Percent or Less of a Class   
      Not applicable      
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.      
Item 6.    Ownership of More than Five Percent on behalf of Another Person.      
      Not applicable      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
      Not applicable      
Item 8.    Identification and Classification of Members of the Group      
      Not applicable      
Item 9.    Notice of Dissolution of Group      
      Not applicable      
Item 10.    Certification      
      Not applicable      

 

Page 4 of 5


STATEMENT ON SCHEDULE 13G/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 13, 2009
Date

/s/ Chancey Graziano

Signature
Chancey Graziano
Name

 

Page 5 of 5